Source: PR Newswire

Press Release: Nuvo Pharmaceuticals : Nuvo Pharmaceuticals Announces Receipt of Shareholder Approval By Way of Written Consent For the Issuance of Common Shares Pursuant to Convertible Notes and Warrants

MISSISSAUGA, ON, March 11, 2019 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI; OTCQX:NRIFF) today announced that it has obtained consents from shareholders of the Company (Shareholders) holding, in the aggregate, more than 50% of the Company's issued and...

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Jesse Ledger's photo - President & CEO of Nuvo Pharmaceuticals

President & CEO

Jesse Ledger

CEO Approval Rating


Nuvo is a healthcare company that manufactures and commercializes pharmaceutical products for the topical pain relief. Read more